- Home
- NRXP vs REFR Comparison
NRXP vs REFR Comparison
Compare NRXP & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- REFR
- Stock Information
- Founded
- NRXP 2015
- REFR 1965
- Country
- NRXP United States
- REFR United States
- Employees
- NRXP N/A
- REFR N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- REFR Multi-Sector Companies
- Sector
- NRXP Health Care
- REFR Miscellaneous
- Exchange
- NRXP Nasdaq
- REFR Nasdaq
- Market Cap
- NRXP 58.5M
- REFR 49.5M
- IPO Year
- NRXP N/A
- REFR N/A
- Fundamental
- Price
- NRXP $3.05
- REFR $1.40
- Analyst Decision
- NRXP Strong Buy
- REFR
- Analyst Count
- NRXP 5
- REFR 0
- Target Price
- NRXP $31.40
- REFR N/A
- AVG Volume (30 Days)
- NRXP 498.6K
- REFR 22.5K
- Earning Date
- NRXP 11-13-2025
- REFR 11-06-2025
- Dividend Yield
- NRXP N/A
- REFR N/A
- EPS Growth
- NRXP N/A
- REFR N/A
- EPS
- NRXP N/A
- REFR N/A
- Revenue
- NRXP N/A
- REFR $1,222,239.00
- Revenue This Year
- NRXP N/A
- REFR N/A
- Revenue Next Year
- NRXP $231.16
- REFR N/A
- P/E Ratio
- NRXP N/A
- REFR N/A
- Revenue Growth
- NRXP N/A
- REFR N/A
- 52 Week Low
- NRXP $1.10
- REFR $0.93
- 52 Week High
- NRXP $6.01
- REFR $2.35
- Technical
- Relative Strength Index (RSI)
- NRXP 58.85
- REFR 51.92
- Support Level
- NRXP $2.91
- REFR $1.24
- Resistance Level
- NRXP $3.18
- REFR $1.33
- Average True Range (ATR)
- NRXP 0.24
- REFR 0.07
- MACD
- NRXP 0.04
- REFR 0.02
- Stochastic Oscillator
- NRXP 87.19
- REFR 79.17
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.